Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Marketing Approval for Medical Devices in European Union


Affiliations
1 Department of Pharmaceutical Regulatory Affairs, SRM Institute of Science and Technology, SRM College of Pharmacy, Kattankulathur-603203 Dist – Kancheepuram, India
     

   Subscribe/Renew Journal


The demand of medical devices has risen globally, especially in Europe. The devices regulated in Europe must ensure the safety and effectiveness of these products. There are various principles to approve the medical devices in the European market. The biggest companies are in Germany (27%), UK (11%), Italy, Switzerland, Spain and France (16%). The Europe has very good gobal impact in medical device marketing. The classification is based upon risk management, the medium and high risk requires the conformity assessment (CE marking) done by Notified bodies. There are four levels of classification of devices. Various EU directives that has impact on medical devices. International medical device regulatory forum (IMDRF), is followed by regulatory department of countries like Austrila, Brazil, Canada, China, EU, Japan, the United States, and WHO. The approved medical devices in European market must ensure the best protection of patient health. The development timelines for Noval drug and chemical entity take much longer time compared to medical devices. There are about 500,000 life supporting machines in which 20,000 are of generic group. Various rules on clinical evaluation and clinical investigation help in strengthening the regulatory system in Europe. To explore in marketing level premarket testing and postmarked vigilance is required.

Keywords

Medical Devices, CE Marking, Notified Bodies, European Market, IMDRF.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Bikash Chatterjee,Preparing for the new European medical device regulations, Pharmatech Associates, 2017.

  • Christa Alenstter. “EU and member state medical devices regulation”, International Journal of Technology Assessment in Health Care, 01/2003.

  • European Commission. Classification of medical devices (MEDDEV 2.4/1 Rev. 9). June 2010.

  • European Council. Directive 93/42/EEC concerning medical devices. June 14, 199.

  • Heneghan C, Thompson M, Billingsley M, Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts. BMJ open 2011.

  • European Commission. Medical devices: guidance MEDDEVs. June 10, 2011.

  • CE marking: the fast route to compliance in the European Union. Hertfordshire, United Kingdom, BSI.

  • Schreyogg J, Baumler M, Busee R. Balancing adoption and affordability of medical devices in Europe. Health Policy 2009;92:218-224.

  • Teysseyre, Patricia. “European Union: Medical Device Regulatory System”, Hamdbook of Medical Device Regulatory Affairs in Asia, 2013.

  • Global Medical Device Nomenclature (GMDN) Agency, 2010.

  • CE marking: the fast route to compliance in the European Union. Hertfordshire, United Kingdom, BSI (http;/www/bsigroup.com/upload/product%20Services/About%20CE%20marking/CE Brochure) 2010 pdf.

  • European Commission. Medical devices: Council of the European Union. Council Directive 2007/47/EC. September 21, 2007.

  • Commission decision 2010/227/EU of 19 April 2010 on the European Databank on medical devices (EUDAMED). 2010 http://eurdlex.europaeu/LexUriServ.do?uri=OJ:L2010:1020045:0048:EU:PDF,last accessed 2-1-2015.


Abstract Views: 234

PDF Views: 0




  • Marketing Approval for Medical Devices in European Union

Abstract Views: 234  |  PDF Views: 0

Authors

D. Bhavyasri
Department of Pharmaceutical Regulatory Affairs, SRM Institute of Science and Technology, SRM College of Pharmacy, Kattankulathur-603203 Dist – Kancheepuram, India
K. Manikandan
Department of Pharmaceutical Regulatory Affairs, SRM Institute of Science and Technology, SRM College of Pharmacy, Kattankulathur-603203 Dist – Kancheepuram, India
R. Kamaraj
Department of Pharmaceutical Regulatory Affairs, SRM Institute of Science and Technology, SRM College of Pharmacy, Kattankulathur-603203 Dist – Kancheepuram, India

Abstract


The demand of medical devices has risen globally, especially in Europe. The devices regulated in Europe must ensure the safety and effectiveness of these products. There are various principles to approve the medical devices in the European market. The biggest companies are in Germany (27%), UK (11%), Italy, Switzerland, Spain and France (16%). The Europe has very good gobal impact in medical device marketing. The classification is based upon risk management, the medium and high risk requires the conformity assessment (CE marking) done by Notified bodies. There are four levels of classification of devices. Various EU directives that has impact on medical devices. International medical device regulatory forum (IMDRF), is followed by regulatory department of countries like Austrila, Brazil, Canada, China, EU, Japan, the United States, and WHO. The approved medical devices in European market must ensure the best protection of patient health. The development timelines for Noval drug and chemical entity take much longer time compared to medical devices. There are about 500,000 life supporting machines in which 20,000 are of generic group. Various rules on clinical evaluation and clinical investigation help in strengthening the regulatory system in Europe. To explore in marketing level premarket testing and postmarked vigilance is required.

Keywords


Medical Devices, CE Marking, Notified Bodies, European Market, IMDRF.

References